CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease

Pharmacogenetics

Volumn 9, Issue 1, 1999, Pages 31-35

  Atkinson, Andrea ^a,c   Singleton, Andrew B ^a   Steward, Annette ^a   Ince, Paul G ^a   Perry, Robert H ^a   McKeith, Ian G ^a   Fairbairn, Andrew F ^a   Edwardson, James A ^a   Daly, Anne K ^b   Morris, Christopher M ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; CYP2D6; Dementia with Lewy Bodies; Parkinson's disease

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE; SUBSTANTIA NIGRA;

PARKINSONIA;

EID: 0032918986     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199902000-00005     Document Type: Article

References (48)

1. Agúndez JA, Jimenez-Jimenez FJ, Luengo A, Bernal ML, Molina JA, Ayuso L, et al. Association between the oxidative polymorphism and early onset of Parkinson's disease. Clin Pharmacol Ther 1995; 57:291-298.
2. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992; 339:1017-1018.
3. Bandmann O, Vaugban J, Holmans P, Marsden CD, Wood NW. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997;350:1136-1139.
4. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994; 343:1565.
5. Borgem ALM. Heredity in dementia of the Alzheimer type. Clin Genet 1994; 46:144-149.
6. Bétard C, Robitaille Y, Gee M, Tiberghien D, Larrivée D, Roy P, et al. Apo E allele frequencies in Alzheimer's disease and vascular dementia. Neuroreport 1994; 5:1893-1896.
7. Bordet R, Broly F, Destee A, Libersa C. Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body discase. Clin Neuropharmacol 1994; 17:484-488.
8. Bordet R, Broly F, Destee A, Libersa C, Laffitte JJ. Lack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease. Clin Neuropharmacol 1996; 19:213-221.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993:261:921-921
10. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. Association of a polymorphism in intron 1 3 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 1997; 74:154-156.
11. Duly AK, Brockmöller J, Broly F, Eiehclbaum M, Evans WE, Gonzalez FJ, et al. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996a; 6:193-201.
12. Daly AK, Steen VM, Fairbrother KS, Idle JR. CYP2D6 multiallelism. Methods Enzymol 1996b; 272:199-210.
13. De Michele G, Filla A, Marconi R, Volpe G, D'Alessio A, Scala R, et al. A genetic study of Parkinson's disease. J Neural Transm 1995; 45 (suppl):21-25.
14. Dickson DW, Schmidt ML, Lee VM, Zhao ML, Yen SH, Trojanowski JC. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropath. 1994; 87:269-276.
15. Duvoisin RC, Johnson WG. Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease. Brain Pathol 1992; 2:309-320.
16. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L. The apolipoprotein E allele ε4 is over represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44:1950-1951.
17. Golbe LI. The genetics of Parkinson's disease. Rev Neurosci 1993: 4:1-16.
18. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry Rh, Perry EK, et al. Influence of Apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Path. 1994; 145:1472-1484.
19. Hoda F, Nicholl D, Bennet P, Arranz M, Aitchison KJ, al-Chalibi A, et al. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochem Biophys Res Commun. 1996; 228:780-784.
20. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31:545-548.
21. Hotamisligil GS, Girmen AS, Fink JS, TiVol. E, Shalish C, Trofatter J. 'et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 1994:9, 305-310.
22. Johnson WG, Hodge SE, Duvoisin R. Twin studies and the genetics of Parkinson's disease - a reappraisal. Mov Disord 1990; 5:187-194.
23. Koller WC, Glatt SL, Hubble JP, Paolo A, Tröster AI, Handler MS, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neural 1995; 37:242-245.
24. Kurth MC, Kurth JH. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet 1993; 48:166-168.
25. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of amonoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993; 33:368-372.
26. Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, et al. Apolipoprotein E and alpha-I anti-chymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies: distinctions between diseases. Neurology 1998; 50:388-391.
27. Le Couteur DG, Leighton PW, McCann SJ, Pond SM. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov Disord 1997; 12:760-763.
28. Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Davies P, et al. Apolipoprotein E genotype and Lewy body disease. Neurology 1995; 45:97-103.
29. Lucotte G, Turpin JC, Gerard N, Panserat S, Krishnamoorthy K. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families. Am J Med Genet 1996; 67:361-365.
30. Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, et al. The apolipoprotein ε4 allele in Parkinson's disease with and without dementia. Neurology 1994; 44:1330-1331.
31. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of the Lewy body type (SDLT). Psychol Med 1992; 22:911-922.
32. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 1996; 47:1113-1124.
33. Morris CM, Massey HM, Benjamin R, Leake A, Broadbent C, Griffiths M, el al. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. J Neural Transm 1996; 47:205-218.
34. Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, et al. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms Am J Med Genet 1994; 54:361-364.
35. Nanko S, Ueki A, Hattori M. No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms. Neurosci Lett 1996; 204:125-127.
36. Perry KH, Irving D, Blessed G, Fairbairn A, Perry EK, Senile dementia of the Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95:119-139.
37. Pickering-Brown SM, Mann DMA, Bourke JP, Roberts DA, Balderson D, Burns A, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet 1944; 343:1155.
38. Plante-Bordencuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neural Neurosurg Psychiatry 1994; 57:911-913.
39. Plante-Bordencuve V, Taussig D, Thomas F, Said G, Wood NW, Marsden CD, Harding AE. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997; 48:1589-1593.
40. Poirer J, Davignon J, Bouthillier D, Kogan S, Bertrand D, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342:697-699.
41. Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, et al. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neural 1995; 37:110-112.
42. Sandy MS, Armstrong M, Tanner CM, Daly AK, DiMonte DA, Langston JW, Idle JR. CYP2D6 allele frequencies in young onset Parkinson's disease. Neurology 1996; 47:225-230.
43. Saunders AM, Strittmatter WJ, Schmechel D, St George Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472.
44. Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, Maraganore DM, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339:1375-1377.
45. Vieregge P. Genetic factors in the etiology of idiopathic Parkinson's disease J Neural Transm Park Dis Dement Sect 1994; 8:1-37.
46. Vieregge P, Schiffke KA, Friedrich HJ, Muller B, Ludin HP. Parkinson's disease in twins. Neurology 1992; 42:1453-1461.
47. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159.
48. Wilhelmsen K, Mirel D, Marder K, Bernstein M, Naini A, Leal SM, et al. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13? Ann Neurol 1997; 41:813-817.